Home › FDA Approves Efavirenz (Sustiva) for HIV+ Children Ages 3 Months to 3 Years
 

Keywords :   


FDA Approves Efavirenz (Sustiva) for HIV+ Children Ages 3 Months to 3 Years

2013-05-04 18:02:12| Biotech - Topix.net

Below is an edited excerpt from a press release issued by Sustiva producer Bristol-Myers Squibb describing the approval in more detail.

Tags: to years months children

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
23.06Atlantic Tropical Weather Outlook
23.06Eastern North Pacific Tropical Weather Outlook
22.06AI and agriculture: A look at whats ahead
22.06Atlantic Tropical Weather Outlook
22.06Atlantic Tropical Weather Outlook
22.06Eastern North Pacific Tropical Weather Outlook
22.06This Week in Agribusiness, June 22, 2024
22.06This Week in Agribusiness, June 22, 2024
More »